ClearPoint Neuro (CLPT) Free Cash Flow Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 22.80% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -27.72% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -0.27% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 77.20% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -20.37% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.32% |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | -13.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.97% |
| Dec 31, 2025 | -57.40% |
| Sep 30, 2025 | 5.40% |
| Jun 30, 2025 | 19.45% |
| Mar 31, 2025 | -13.57% |
| Dec 31, 2024 | 25.14% |
| Sep 30, 2024 | 29.26% |
| Jun 30, 2024 | 10.19% |
| Mar 31, 2024 | -20.94% |
| Dec 31, 2023 | 20.86% |
| Sep 30, 2023 | -14.11% |
| Jun 30, 2023 | -46.75% |
| Mar 31, 2023 | -35.65% |
| Dec 31, 2022 | -88.14% |
| Sep 30, 2022 | -59.62% |
| Jun 30, 2022 | -84.13% |
| Mar 31, 2022 | -92.36% |
| Dec 31, 2021 | -83.27% |
| Sep 30, 2021 | -51.37% |
| Jun 30, 2021 | -47.70% |
| Mar 31, 2021 | -3.09% |
| Mar 31, 2019 | 28.77% |
| Dec 31, 2018 | -26.76% |
| Sep 30, 2018 | 16.06% |
| Jun 30, 2018 | 26.83% |
| Mar 31, 2018 | 10.95% |
| Mar 31, 2016 | 9.18% |
| Dec 31, 2015 | 108.33% |
| Sep 30, 2015 | 5.29% |
| Jun 30, 2015 | -26.31% |
| Mar 31, 2015 | -14.10% |
| Dec 31, 2014 | 119.82% |
| Sep 30, 2014 | -17.68% |
| Jun 30, 2014 | 3.35% |
| Mar 31, 2014 | 4.61% |